Magdy El-Salhy

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 22

Top Venues

Digestive diseases and sciences

Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society

Scandinavian journal of gastroenterology

Gut

Univerity of Bergen

Uppsala Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Univerity of Bergen

Norway

Professor/consultant gastroenterologist :: Clinical Medicine

Education History

Uppsala Universitet

Sweden

PHD :: Medicine

Publications

Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy, Jan Gunnar Hatlebakk
Factors Underlying the Difference in Response to Fecal Microbiota Transplantation Between IBS Patients with Severe and Moderate Symptoms. Digestive diseases and sciences 69 (4) (2024)
Magdy El-Salhy
Intestinal bacteria associated with irritable bowel syndrome and chronic fatigue. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk
Letter: A step forward towards a standard FMT protocol for IBS. Alimentary pharmacology & therapeutics 58 (10) (2023)
Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk
Factors affecting the outcome of fecal microbiota transplantation for patients with irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2023)
Magdy El-Salhy, Tarek Mazzawi, Trygve Hausken, Jan Gunnar Hatlebakk
The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms. Scandinavian journal of gastroenterology 57 (9) (2022)
Tarek Mazzawi, Trygve Hausken, Magdy El-Salhy
Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation. Scandinavian journal of gastroenterology 57 (7) (2022)
Magdy El-Salhy, Tarek Mazzawi, Trygve Hausken, Jan Gunnar Hatlebakk
Irritable bowel syndrome patients who are not likely to respond to fecal microbiota transplantation. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 34 (9) (2022)
Magdy El-Salhy, Anja Bråthen Kristoffersen, Jørgen Valeur, Christina Casen, Jan Gunnar Hatlebakk, Odd Helge Gilja, Trygve Hausken
Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)
Magdy El-Salhy, Trygve Hausken, Jan Gunnar Hatlebakk
Current status of fecal microbiota transplantation for irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 33 (11) (2021)
Magdy El-Salhy, Tanisa Patcharatrakul, Sutep Gonlachanvit
The role of diet in the pathophysiology and management of irritable bowel syndrome. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 40 (2) (2021)
Magdy El-Salhy, Jørgen Valeur, Trygve Hausken, Jan Gunnar Hatlebakk
Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 33 (2) (2020)
Magdy El-Salhy
FMT in IBS: how cautious should we be? Gut 70 (3) (2020)
Magdy El-Salhy, Trygve Hausken, Jan Gunnar Hatlebakk
Letter: faecal microbiota transplantation for irritable bowel syndrome-which improvements are required? Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Magdy El-Salhy, Jan Gunnar Hatlebakk, Odd Helge Gilja, Anja Bråthen Kristoffersen, Trygve Hausken
Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 69 (5) (2019)
Tarek Mazzawi, Trygve Hausken, Johannes Roksund Hov, Jørgen Valeur, Dag André Sangnes, Magdy El-Salhy, Odd Helge Gilja, Jan Gunnar Hatlebakk, Gülen Arslan Lied
Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels. Scandinavian journal of gastroenterology 54 (6) (2019)
Magdy El-Salhy, Odd Helge Gilja, Doris Gundersen, Jan Gunnar Hatlebakk, Trygve Hausken
Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome. Gastroenterology research and practice 2014 (2014)
Magdy El-Salhy, Kazuo Umezawa, Odd Helge Gilja, Jan G Hatlebakk, Doris Gundersen, Trygve Hausken
Amelioration of severe TNBS induced colitis by novel AP-1 and NF- κ B inhibitors in rats. TheScientificWorldJournal 2014 (2014)

Magdy El-Salhy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Magdy El-Salhy